GSM城市站国家站

报告称特朗普药企持股最高达5620万美元 含3910万美元投向受益于医保谈判豁免的公司 白宫否认利益冲突

2026-10-17 · 金融 · GSM News
报告称特朗普药企持股最高达5620万美元 含3910万美元投向受益于医保谈判豁免的公司 白宫否认利益冲突

据美联社报道,美国国会联合经济委员会民主党一方10月16日(周五)发布报告称,以特朗普总统名义进行的制药公司投资在其重返白宫后显著增加:其药企股票持仓的申报最高值从2024年的170万美元,增至2025年底的最高5,620万美元。报告称,其中最高3,910万美元投向了因共和党2025年税收与支出法案条款而获得联邦医疗保险(Medicare)药价谈判豁免的公司。

报告对特朗普财务披露的进一步分析显示,其投资组合在2025年7月他签署该法案前的三个日期,买入了最高255万美元的受益于豁免的药企股票,其中包括参议院通过法案当天(7月1日)买入的最高95万美元;法案生效后的2025年8月,又买入了最高100万美元的 AbbVie 股票。报告还称,豁免政策可能使部分 Medicare 受益人购买某些癌症治疗等药物的费用比允许谈判时高出数千美元。

白宫方面否认存在道德问题,指责民主党人「企图捏造利益冲突」。美联社报道指出,特朗普就任以来财富通过一系列商业利益增长,其中不少受益于其政府的政策动作;白宫已多次否认相关质疑。

Report: Trump's Drugmaker Holdings Rose to as Much as $56.2M, Including $39.1M in Firms Shielded From Medicare Talks; White House Denies Conflict

Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House, according to a report released on Friday, October 16, by the minority arm of Congress's Joint Economic Committee, the Associated Press reported. The report found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025, including up to $39.1 million in companies that benefited from exemptions to Medicare's drug price negotiation program under a provision in Republicans' 2025 tax and spending law.

Additional analysis of Trump's financial disclosures provided by committee Democrats showed that his portfolio bought as much as $2.55 million in shares of pharmaceutical companies benefiting from the exemptions on three dates before he signed the legislation in July 2025, including up to $950,000 on July 1, 2025, the day the Senate passed the bill. His portfolio also bought as much as $1 million in AbbVie stock in August 2025, after the bill became law. The report also said the exemptions could leave some Medicare beneficiaries paying thousands of dollars more for certain cancer treatments and other medications than they would if Medicare had been allowed to negotiate lower prices.

The White House has repeatedly denied any ethics issues and accused Democrats of attempts to fabricate conflicts of interest. The AP noted that Trump's wealth has grown since he took office through a web of business interests, many of which have benefited from his administration's policy moves.

发布:GSM·美国(发布链接)

图片来源:资料图:白宫北立面。File photo: The north front of the White House.

GSM Global · 本篇英文版 English edition of this story

本频道最新更多 ›

← 返回金融 全部新闻 关于我们

GSM首页白宫联邦加州南加社区各州社会选举世界中国外交城市站国家站司法移民宣传专题视频直播放映厅电子书科技金融教育医疗影视音乐体育文旅时尚演出活动娱乐游戏生活美食户外交通汽车地产保险儿童长者留学生宠物信仰非盈利机构